| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &General Counsel | EVP &General Counsel
1 company
Mahon Paul A is an EVP &General Counsel at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 30 sells.
Estimated insider holdings value: $20.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $182.42 | $1,094,501.22 | -3.8% | +19.3% | +19.1% | |
| Mar 3, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $174.12 | $1,044,714.72 | -7.6% | +32.2% | +42.1% | |
| Feb 17, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $202.17 | $1,213,023.67 | -4.5% | -7.3% | +27.9% | |
| Feb 3, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $200.10 | $1,200,615.66 | -8.5% | -6.2% | +27.2% | |
| Jan 20, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $205.57 | $1,233,440.17 | -5.9% | -6.4% | +30.9% | |
| Jan 6, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $192.46 | $1,154,786.96 | -5.7% | -5.4% | +40.9% | |
| Dec 16, 2021 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $195.53 | $1,173,171.47 | -4.9% | -6.8% | +42.4% | |
| Dec 2, 2021 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $189.36 | $1,136,140.14 | -3.7% | -7.4% | +47.2% | |
| Nov 4, 2021 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $201.19 | $1,207,153.00 | -5.1% | +0.3% | +31.4% | |
| Oct 21, 2021 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $190.18 | $1,141,081.50 | -7.3% | +7.6% | +15.0% |